Diagnostic Accuracy of Slow-Capillary Endobronchial Ultrasound Needle Aspiration in Determining PD-L1 Expression in Non-Small Cell Lung Cancer.

IF 1.8 Q3 RESPIRATORY SYSTEM
Lina Zuccatosta, Federico Mei, Michele Sediari, Alessandro Di Marco Berardino, Martina Bonifazi, Francesca Barbisan, Gaia Goteri, Stefano Gasparini, Francesca Gonnelli
{"title":"Diagnostic Accuracy of Slow-Capillary Endobronchial Ultrasound Needle Aspiration in Determining PD-L1 Expression in Non-Small Cell Lung Cancer.","authors":"Lina Zuccatosta,&nbsp;Federico Mei,&nbsp;Michele Sediari,&nbsp;Alessandro Di Marco Berardino,&nbsp;Martina Bonifazi,&nbsp;Francesca Barbisan,&nbsp;Gaia Goteri,&nbsp;Stefano Gasparini,&nbsp;Francesca Gonnelli","doi":"10.3390/arm91010001","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The role of EBUS-TBNA in the diagnosis and staging of lung cancer is well established. EBUS-TBNA can be performed using different aspiration techniques. The most common aspiration technique is known as \"suction\". One alternative to the suction technique is the slow-pull capillary aspiration. To the best of our knowledge, no studies have assessed the diagnostic yield of slow-pull capillary EBUS-TBNA in PD-L1 amplification assessment in NSCLC. Herein, we conducted a single-centre retrospective study to establish the diagnostic yield of slow-pull capillary EBUS-TBNA in terms of PD-L1 in patients with NSCLC and hilar/mediastinal lymphadenopathies subsequent to NSCLC.</p><p><strong>Materials and methods: </strong>Patients with hilar and/or mediastinal lymph node (LN) NSCLC metastasis, diagnosed by EBUS-TBNA between January 2021 and April 2022 at Pulmonology Unit of \"Ospedali Riuniti di Ancona\" (Ancona, Italy) were enrolled. We evaluated patient characteristics, including demographic information, CT scan/ FDG-PET features and final histological diagnoses, including PD-L1 assessment.</p><p><strong>Results: </strong>A total of 174 patients underwent EBUS-TBNA for diagnosis of hilar/mediastinal lymphadenopathies between January 2021 and April 2022 in the Interventional Pulmonology Unit of the \"Ospedali Riuniti di Ancona\". Slow-pull capillary aspiration was adopted in 60 patients (34.5%), and in 30/60 patients (50.0%) NSCLC was diagnosed. EBUS-TBNA with slow-pull capillary aspiration provided adequate sampling for molecular biology and PD-L1 testing in 96.7% of patients (29/30); in 15/29 (51.7%) samples with more than 1000 viable cells/HPF were identified, whereas in 14/29 (48.3%) samples contained 101-1000 viable cells/HPF.</p><p><strong>Conclusion: </strong>These retrospective study shows that slow-pull capillary aspiration carries an excellent diagnostic accuracy, almost equal to that one reported in literature, supporting its use in EBUS-TBNA for PD-L1 testing in NSCLC.</p>","PeriodicalId":7391,"journal":{"name":"Advances in respiratory medicine","volume":"91 1","pages":"1-8"},"PeriodicalIF":1.8000,"publicationDate":"2023-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844495/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in respiratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/arm91010001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: The role of EBUS-TBNA in the diagnosis and staging of lung cancer is well established. EBUS-TBNA can be performed using different aspiration techniques. The most common aspiration technique is known as "suction". One alternative to the suction technique is the slow-pull capillary aspiration. To the best of our knowledge, no studies have assessed the diagnostic yield of slow-pull capillary EBUS-TBNA in PD-L1 amplification assessment in NSCLC. Herein, we conducted a single-centre retrospective study to establish the diagnostic yield of slow-pull capillary EBUS-TBNA in terms of PD-L1 in patients with NSCLC and hilar/mediastinal lymphadenopathies subsequent to NSCLC.

Materials and methods: Patients with hilar and/or mediastinal lymph node (LN) NSCLC metastasis, diagnosed by EBUS-TBNA between January 2021 and April 2022 at Pulmonology Unit of "Ospedali Riuniti di Ancona" (Ancona, Italy) were enrolled. We evaluated patient characteristics, including demographic information, CT scan/ FDG-PET features and final histological diagnoses, including PD-L1 assessment.

Results: A total of 174 patients underwent EBUS-TBNA for diagnosis of hilar/mediastinal lymphadenopathies between January 2021 and April 2022 in the Interventional Pulmonology Unit of the "Ospedali Riuniti di Ancona". Slow-pull capillary aspiration was adopted in 60 patients (34.5%), and in 30/60 patients (50.0%) NSCLC was diagnosed. EBUS-TBNA with slow-pull capillary aspiration provided adequate sampling for molecular biology and PD-L1 testing in 96.7% of patients (29/30); in 15/29 (51.7%) samples with more than 1000 viable cells/HPF were identified, whereas in 14/29 (48.3%) samples contained 101-1000 viable cells/HPF.

Conclusion: These retrospective study shows that slow-pull capillary aspiration carries an excellent diagnostic accuracy, almost equal to that one reported in literature, supporting its use in EBUS-TBNA for PD-L1 testing in NSCLC.

慢毛细支气管内超声针吸检测非小细胞肺癌PD-L1表达的诊断准确性。
EBUS-TBNA在肺癌的诊断和分期中的作用已经得到了很好的证实。EBUS-TBNA可以使用不同的吸入技术进行。最常见的抽吸技术是“抽吸”。另一种抽吸技术是慢拉式毛细管抽吸。据我们所知,目前还没有研究评估慢拉毛细血管EBUS-TBNA在非小细胞肺癌PD-L1扩增评估中的诊断率。在此,我们进行了一项单中心回顾性研究,以确定慢拉毛细血管EBUS-TBNA对非小细胞肺癌和肺门/纵隔淋巴结病变患者PD-L1的诊断率。材料和方法:入选2021年1月至2022年4月在意大利安科纳(Ancona, Italy)“Ospedali Riuniti di Ancona”肺病科通过EBUS-TBNA诊断的肺门和/或纵隔淋巴结(LN) NSCLC转移患者。我们评估了患者的特征,包括人口统计学信息、CT扫描/ FDG-PET特征和最终的组织学诊断,包括PD-L1评估。结果:2021年1月至2022年4月,共有174例患者在安科纳国立医院介入肺科接受了EBUS-TBNA诊断肺门/纵隔淋巴结病。60例(34.5%)患者采用慢拉式毛细管抽吸,其中30/60例(50.0%)患者被诊断为NSCLC。96.7%的患者(29/30)采用慢拉式毛细管抽吸EBUS-TBNA为分子生物学和PD-L1检测提供了足够的样本;15/29(51.7%)的样品活细胞/HPF大于1000个,14/29(48.3%)的样品活细胞/HPF为101 ~ 1000个。结论:本回顾性研究显示,慢拉式毛细管抽吸具有极好的诊断准确性,几乎与文献报道的诊断准确性相当,支持将其用于EBUS-TBNA检测非小细胞肺癌的PD-L1。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advances in respiratory medicine
Advances in respiratory medicine RESPIRATORY SYSTEM-
CiteScore
2.60
自引率
0.00%
发文量
90
期刊介绍: "Advances in Respiratory Medicine" is a new international title for "Pneumonologia i Alergologia Polska", edited bimonthly and addressed to respiratory professionals. The Journal contains peer-reviewed original research papers, short communications, case-reports, recommendations of the Polish Respiratory Society concerning the diagnosis and treatment of lung diseases, editorials, postgraduate education articles, letters and book reviews in the field of pneumonology, allergology, oncology, immunology and infectious diseases. "Advances in Respiratory Medicine" is an open access, official journal of Polish Society of Lung Diseases, Polish Society of Allergology and National Research Institute of Tuberculosis and Lung Diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信